There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:C07K14/725
Jump to navigation
Jump to search
Subcategories
This category has the following 2 subcategories, out of 2 total.
Pages in category "C07K14/725"
The following 35 pages are in this category, out of 35 total.
1
- 17995083. Genetically Engineered Phagocytes, and Related Compositions, Vectors, Methods and Systems simplified abstract (The Regents of the University of California)
- 18260377. ANTI-CD72 NANOBODIES FOR IMMUNOTHERAPY simplified abstract (The Regents of the University of California)
- 18274979. IMMUNE RECEPTORS WITH SYNTHETIC CO-STIMULATORY DOMAINS simplified abstract (The Regents of the University of California)
- 18442444. Non-Human Animals Expressing Humanized CD3 Complex simplified abstract (Regeneron Pharmaceuticals, Inc.)
- 18482223. HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE simplified abstract (The Board of Trustees of the Leland Stanford Junior University)
- 18548481. TARGETING T REGULATORY CELLS TO ISLET CELLS TO STALL OR REVERSE TYPE 1 DIABETES simplified abstract (The Trustees of the University of Pennsylvania)
- 18552131. HYBRID RECEPTORS WITH MULTIPLE TRANSCRIPTIONAL REGULATORS simplified abstract (The Regents of the University of California)
- 18558882. DOUBLE SIDED CHIMERIC ANTIGEN RECEPTOR (CAR) ENGINEERED CELL MEMBRANE BASED DRUG DELIVERY SYSTEMS simplified abstract (BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM)
- 18560003. STRUCTURE BASED ISOLATION OF PMHC-RESTRICTED ANTIBODIES simplified abstract (THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY)
- 18609414. HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (Novartis AG)
- 18609414. HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (The Trustees of the University of Pennsylvania)
- 18620748. Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T cells Against T Cell Lymphomas and Leukemias simplified abstract (The Trustees of the University of Pennsylvania)
- 18643312. BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 and CD20 simplified abstract (The Regents of the University of California)
- 18750233. ENHANCED CHIMERIC ANTIGEN RECEPTORS AND USE THEREOF simplified abstract (Board of Regents, The University of Texas System)
- 18776496. DISRUPTING TUMOR TISSUES BY TARGETING FIBROBLAST ACTIVATION PROTEIN (FAP) (The Trustees of the University of Pennsylvania)
B
F
M
T
- The regents of the university of california (20240261334). BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 and CD20 simplified abstract
- The regents of the university of california (20240293463). BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 and CD20 simplified abstract
- The regents of the university of california (20240293545). Genetically Engineered Phagocytes, and Related Compositions, Vectors, Methods and Systems simplified abstract
- The regents of the university of california (20240299449). ANTI-CD72 NANOBODIES FOR IMMUNOTHERAPY simplified abstract
- The regents of the university of california (20240299545). HYBRID RECEPTORS WITH MULTIPLE TRANSCRIPTIONAL REGULATORS simplified abstract
- The regents of the university of california (20240408137). METHODS FOR MAKING AND USING THERAPEUTIC CELLS
- The regents of the university of california (20240408204). Methods of Treating Lymphoma with a Phagocyte Having a Chimeric Antigen Receptor
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA patent applications on August 8th, 2024
- The Regents of the University of California patent applications on December 12th, 2024
- The Regents of the University of California patent applications on September 12th, 2024
- The Regents of the University of California patent applications on September 5th, 2024
